Stock-Based Compensation

$121.89M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$121.89Mperiod endingJun 30, 2026

BCRX Stock-Based Comp ($0.00 → $121.89M)

Annual stock-based compensation

High-resolution chart · PNG

BCRX stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	85,066,000
Dec 31, 2024	65,413,000
Dec 31, 2023	55,615,000
Dec 31, 2022	44,701,000
Dec 31, 2021	34,640,000
Dec 31, 2020	0
Dec 31, 2019	17,719,000
Dec 31, 2018	9,396,000
Dec 31, 2017	12,621,000
Dec 31, 2016	8,487,000
Dec 31, 2015	9,705,000
Dec 31, 2014	10,177,000
Dec 31, 2013	4,368,000
Dec 31, 2012	4,167,000
Dec 31, 2011	4,772,000
Dec 31, 2010	6,301,856
Dec 31, 2009	5,524,883
Dec 31, 2008	5,860,654,000
Dec 31, 2007	5,691,028,000
Dec 31, 2006	3,338,761,000
Dec 31, 2005	26,392,000
Dec 31, 2004	512,427,000
Dec 31, 2003	119,676,000
Dec 31, 2002	120,190,000
Dec 31, 2001	123,289,000
Dec 31, 2000	104,529,000
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0